Olanzapine (Zyprexa): increased incidence of cerebrovascular events in dementia trials

Abstract

Reason for posting: Second-generation antipsychotic drugs, which are felt to have fewer extrapyramidal adverse effects than the first-generation drugs,[1][1] are sometimes used to control behavioural disturbances in elderly patients with dementia. However, similar to warnings issued in the last 2